Lucy Bradley, 29, found out about her condition through the NHS app – and spent days waiting to speak to a medical ...
Reduced kidney function from chronic kidney disease may undermine the accuracy of blood-based biomarkers used to predict AD outcomes.
Lumitrace injection, together with the MediBeacon ® TGFR Monitor and MediBeacon ® TGFR Sensor, allow assessment of kidney function by measuring the clearance rate of the fluorescent agent as it leaves ...
19hon MSN
Nearly 90% of adults are at risk for this condition, but most have never heard of it, survey finds
About 9 in 10 adults in the United States have not heard of cardiovascular-kidney-metabolic syndrome despite nearly 90% of ...
Adaptyx Biosciences announced today it has raised $14 million in seed financing, bringing total funding to $23 million since inception. The round was led by Interlagos, with significant participation ...
HORSE RACING By LIAM DURKIN MOE Racing Club welcomed inspiring dual cancer survivor Kate Gale as guest speaker to its [...] ...
A groundbreaking study published in Hypertension , the journal of the American Heart Association, has identified a set of blood-based biomarkers that ...
Irish Star on MSN
10-cent pill 'everyone should try' with promising anti-dementia results hailed by doctor
Dr Amir Khan has shared his thoughts on a popular supplement that he believes everyone should consider taking due to its wide ...
The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...
The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results